about
The contribution of prostaglandins versus prostacyclin in ventricular remodeling during heart failureSubcellular organelle lipidomics in TLR-4-activated macrophagesUltrasound stimulates formation and release of vasoactive compounds in brain endothelial cellsMetabolic profiles in heart failure due to non-ischemic cardiomyopathy at rest and under exerciseTetrandrine blocks cardiac hypertrophy by disrupting reactive oxygen species-dependent ERK1/2 signallingPotent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2.Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.Inhibition of delta-6 desaturase reverses cardiolipin remodeling and prevents contractile dysfunction in the aged mouse heart without altering mitochondrial respiratory function.Comparative genome-wide transcriptional analysis of human left and right internal mammary arteries.TCDD induced pericardial edema and relative COX-2 expression in medaka (Oryzias Latipes) embryosProstanoid receptors involved in regulation of the beating rate of neonatal rat cardiomyocytes.Role of TRP channels in the cardiovascular system.Structure-function of CD36 and importance of fatty acid signal transduction in fat metabolismImproved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodelingActivation of mitochondrial calcium-independent phospholipase A2γ (iPLA2γ) by divalent cations mediating arachidonate release and production of downstream eicosanoids.It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heartCalcium-independent phospholipases A2 and their roles in biological processes and diseases.Comprehensive ultra-performance liquid chromatographic separation and mass spectrometric analysis of eicosanoid metabolites in human samples.CD36 protein influences myocardial Ca2+ homeostasis and phospholipid metabolism: conduction anomalies in CD36-deficient mice during fasting.Mechanism-based inhibition of iPLA2β demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibitionOxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation.omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential.Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism.New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2.Genetic ablation of calcium-independent phospholipase A2{gamma} leads to alterations in hippocampal cardiolipin content and molecular species distribution, mitochondrial degeneration, autophagy, and cognitive dysfunction.Actions and Mechanisms of Polyunsaturated Fatty Acids on Voltage-Gated Ion Channels.Prostaglandin E2 As a Modulator of Viral Infections.Complement factor 5 blockade reduces porcine myocardial infarction size and improves immediate cardiac function.Functional characterization of drug uptake and metabolism in the heart.Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.Cytochrome P450 and ischemic heart disease: current concepts and future directions.Cardiac physiology and clinical efficacy of dietary fish oil clarified through cellular mechanisms of omega-3 polyunsaturated fatty acids.Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKCζ-p53-p21 signaling pathway.Cyclooxygenase-2 Mediated Oxidation of 2-Arachidonoyl-Lysophospholipids Identifies Unknown Lipid Signaling Pathways.Cardiac Myocyte-specific Knock-out of Calcium-independent Phospholipase A2γ (iPLA2γ) Decreases Oxidized Fatty Acids during Ischemia/Reperfusion and Reduces Infarct Size.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.The role of cytochrome P450 1B1 and its associated mid-chain hydroxyeicosatetraenoic acid metabolites in the development of cardiac hypertrophy induced by isoproterenol.Development of cellular hypertrophy by 8-hydroxyeicosatetraenoic acid in the human ventricular cardiomyocyte, RL-14 cell line, is implicated by MAPK and NF-κB.Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway.
P2860
Q26830372-15B64236-4BBD-41D3-AE94-95E57147AE57Q28397617-8C14CA59-EDBC-47BC-AB87-B1FE52B1A89FQ30376498-85F8F5D3-33F0-4BE2-B724-9AD723F7DB8DQ33577400-9C2E1697-1944-4E3B-AB83-48B4D7656007Q33690802-08E9D8FF-DA56-40BE-85CF-DDFE187DC693Q33833653-98C0DF0F-BC7E-49EB-A62A-6C4E73D448D1Q33886495-D305660D-B011-40AC-B7DC-18111185C44CQ33952611-6A785904-5633-4B65-8D37-947CEC43FC02Q34124895-7D955743-F03D-4112-B224-8524242934E9Q34200680-19EC746B-B54E-4979-9092-F43CB9525E32Q34416435-2D24EF3C-64C5-4DAF-99AC-0DBB3CE5C7E4Q35035202-C09260C4-D625-4B4E-8953-B7559F33CD33Q35087570-8A3B7134-C270-4FC5-ADB7-9E94D716E6FCQ35759703-65C3F27D-0DAC-4DEB-A0FD-2DD35AB54F0CQ35922450-D5C5C116-1561-4B3A-90CD-388C5670D30DQ35931476-0C1F240E-CC41-4FF8-9D21-359BB1608A78Q35965050-CCDA00AC-C89D-4D4D-9D22-8183CBD8ADCBQ35994344-28196B5D-1D3A-44FF-99A5-3FF1C5968279Q36118672-AECFF0D1-7C49-48A5-ABF5-D6D03A63E08FQ36385906-F269290D-79EC-4923-9B7B-345763370860Q37027268-580E632A-BB9F-4DAC-BB89-47894EF288B5Q37296539-53D9BAD4-79FC-48D5-87A2-E9E278C3EE9EQ37341044-0BC13BA9-511F-4325-89E3-A0AB7CB53A76Q37408448-99744152-6F62-4060-9357-E2F6E1515D1BQ37443756-89FB424A-8F03-495E-81E0-4563DDB55F20Q37467636-29BDF32F-209F-4C26-9372-3D23C3813391Q37625453-F6FF3D4C-2312-4273-8E60-0DCAE0DA6ED7Q37639791-93D40D7B-496E-4E75-BA71-E8F47CF78306Q37680021-C8B701F2-7988-438E-93D4-4AE8DB82361EQ37922773-E9AD3FB6-F6FF-459C-B45F-1A6DE7959BF0Q38138158-39956F09-274A-48F0-9123-B1B3BFB37E5BQ38166022-40C0043F-2EF0-4429-A127-214CBE4154AAQ38202021-D6A2B750-A1BD-4E91-B5B1-E621AA2ABC4BQ38402718-801058D2-A29D-46B6-849F-6B17609C021DQ38409622-9D30D596-CE48-48DB-BA62-304D3FEA60F1Q38412226-FF5611EA-0B90-43FC-A4B9-D70D78044EE2Q38684679-8B3E20AC-EB93-4C7D-ACC8-3E7278250762Q38714257-5204BC80-17B2-4C12-B312-C986090A5123Q38825803-0FE4BE31-AB73-4AEE-A31B-3C03ECA656A8Q38908564-D49AC02D-B69F-4B41-9031-BB8856C7935F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Eicosanoid signalling pathways in the heart.
@en
Eicosanoid signalling pathways in the heart.
@nl
type
label
Eicosanoid signalling pathways in the heart.
@en
Eicosanoid signalling pathways in the heart.
@nl
prefLabel
Eicosanoid signalling pathways in the heart.
@en
Eicosanoid signalling pathways in the heart.
@nl
P2093
P2860
P356
P1476
Eicosanoid signalling pathways in the heart.
@en
P2093
Ari Cedars
Christopher M Jenkins
Richard W Gross
P2860
P304
P356
10.1093/CVR/CVN346
P577
2008-12-14T00:00:00Z